AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
CLINICAL IMPACT OF PHARMACOKINETICALLY-GUIDED DOSE ADAPTATION OF 5-FLUOROURACIL - RESULTS FROM A MULTICENTRIC RANDOMIZED TRIAL IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS
Authors: FETY R ROLLAND F BARBERIHEYOB M HARDOUIN A CAMPION L CONROY T MERLIN JL RIVIERE A PERROCHEAU G ETIENNE MC MILANO G
Citation: R. Fety et al., CLINICAL IMPACT OF PHARMACOKINETICALLY-GUIDED DOSE ADAPTATION OF 5-FLUOROURACIL - RESULTS FROM A MULTICENTRIC RANDOMIZED TRIAL IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS, Clinical cancer research, 4(9), 1998, pp. 2039-2045
EPIDERMAL GROWTH-FACTOR RECEPTOR AND LABELING INDEX ARE INDEPENDENT PROGNOSTIC FACTORS IN GLIAL TUMOR OUTCOME
Authors: ETIENNE MC FORMENTO JL LEBRUNFRENAY C GIOANNI J CHATEL N PAQUIS P BERNARD C COURDI A BENSADOUN RJ PIGNOL JP FRANCOUAL N GRELLIER P FRENAY M MILANO G
Citation: Mc. Etienne et al., EPIDERMAL GROWTH-FACTOR RECEPTOR AND LABELING INDEX ARE INDEPENDENT PROGNOSTIC FACTORS IN GLIAL TUMOR OUTCOME, Clinical cancer research, 4(10), 1998, pp. 2383-2390
SEARCH FOR THE OPTIMAL SCHEDULE FOR THE OXALIPLATIN 5-FLUOROURACIL ASSOCIATION MODULATED OR NOT BY FOLINIC ACID - PRECLINICAL DATA/
Authors: FISCHEL JL ETIENNE MC FORMENTO P MILANO G
Citation: Jl. Fischel et al., SEARCH FOR THE OPTIMAL SCHEDULE FOR THE OXALIPLATIN 5-FLUOROURACIL ASSOCIATION MODULATED OR NOT BY FOLINIC ACID - PRECLINICAL DATA/, Clinical cancer research, 4(10), 1998, pp. 2529-2535
CO-VARIABLES INFLUENCING 5-FLUOROURACIL CLEARANCE DURING CONTINUOUS VENOUS INFUSION - A NONMEM ANALYSIS
Authors: ETIENNE MC CHATELUT E PIVOT X LAVIT M PUJOL A CANAL P MILANO G
Citation: Mc. Etienne et al., CO-VARIABLES INFLUENCING 5-FLUOROURACIL CLEARANCE DURING CONTINUOUS VENOUS INFUSION - A NONMEM ANALYSIS, European journal of cancer, 34(1), 1998, pp. 92-97
CISPLATIN-RELATED ANEMIA IS LINKED TO PHARMACOKINETIC ABNORMALITIES
Authors: PIVOT X GUARDIOLA E SCHNEIDER M BENSADOUN RJ DASSONVILLE O POISSONNET G THYSS A ETIENNE MC OTTO J MILANO G
Citation: X. Pivot et al., CISPLATIN-RELATED ANEMIA IS LINKED TO PHARMACOKINETIC ABNORMALITIES, Annals of oncology, 9, 1998, pp. 615-615
CONCOMITANT BID RADIOTHERAPY AND CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL IN UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE PHARYNX - CLINICAL AND PHARMACOLOGICAL DATA OF A FRENCH MULTICENTER PHASE-II STUDY
Authors: BENSADOUN RJ ETIENNE MC DASSONVILLE O CHAUVEL P PIVOT X MARCY PY PREVOST B COCHEDEQUEANT B BOURDIN S VALLICIONI J POISSONNET G COURDI A TEISSIER E LAGRANGE JL THYSS A SANTINI J DEMARD F SCHNEIDER M MILANO G
Citation: Rj. Bensadoun et al., CONCOMITANT BID RADIOTHERAPY AND CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL IN UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE PHARYNX - CLINICAL AND PHARMACOLOGICAL DATA OF A FRENCH MULTICENTER PHASE-II STUDY, International journal of radiation oncology, biology, physics, 42(2), 1998, pp. 237-245
THYMIDYLATE SYNTHASE EXPRESSION AND ACTIVITY - RELATION TO S-PHASE PARAMETERS AND 5-FLUOROURACIL SENSITIVITY
Authors: MIRJOLET JF BARBERIHEYOB M MERLIN JL MARCHAL S ETIENNE MC MILANO G BEY P
Citation: Jf. Mirjolet et al., THYMIDYLATE SYNTHASE EXPRESSION AND ACTIVITY - RELATION TO S-PHASE PARAMETERS AND 5-FLUOROURACIL SENSITIVITY, British Journal of Cancer, 78(1), 1998, pp. 62-68
COMBINATION OF IRINOTECAN (CPT11) AND 5-FLUOROURACIL WITH AN ANALYSISOF CELLULAR DETERMINANTS OF DRUG ACTIVITY
Authors: PAVILLARD V FORMENTO P ROSTAGNO P FORMENTO JL FISCHEL JL FRANCOUAL M ETIENNE MC MILANO G
Citation: V. Pavillard et al., COMBINATION OF IRINOTECAN (CPT11) AND 5-FLUOROURACIL WITH AN ANALYSISOF CELLULAR DETERMINANTS OF DRUG ACTIVITY, Biochemical pharmacology, 56(10), 1998, pp. 1315-1322
DECREASED FOLYLPOLYGLUTAMATE SYNTHETASE-ACTIVITY IN TUMORS RESISTANT TO FLUOROURACIL FOLINIC ACID TREATMENT - CLINICAL-DATA
Authors: CHAZAL M CHERADAME S FORMENTO JL FRANCOUAL M FORMENTO P ETIENNE MC FRANCOIS E RICHELME H MOUSSEAU M LETOUBLON C PEZET D CURE H SEITZ JF MILANO G
Citation: M. Chazal et al., DECREASED FOLYLPOLYGLUTAMATE SYNTHETASE-ACTIVITY IN TUMORS RESISTANT TO FLUOROURACIL FOLINIC ACID TREATMENT - CLINICAL-DATA, Clinical cancer research, 3(4), 1997, pp. 553-557
RELEVANCE OF TUMORAL FOLYLPOLYGLUTAMATE SYNTHETASE AND REDUCED FOLATES FOR OPTIMAL 5-FLUOROURACIL EFFICACY - EXPERIMENTAL-DATA
Authors: CHERADAME S ETIENNE MC CHAZAL M GUILLOT T FISCHEL JL FORMENTO P MILANO G
Citation: S. Cheradame et al., RELEVANCE OF TUMORAL FOLYLPOLYGLUTAMATE SYNTHETASE AND REDUCED FOLATES FOR OPTIMAL 5-FLUOROURACIL EFFICACY - EXPERIMENTAL-DATA, European journal of cancer, 33(6), 1997, pp. 950-959
TUMORAL-REDUCED FOLATES AND CLINICAL RESISTANCE TO FLUOROURACIL-BASEDTREATMENT IN HEAD AND NECK-CANCER PATIENTS
Authors: CHERADAME S ETIENNE MC FORMENTO P SCHNEIDER M DASSONVILLE O DEMARD F MILANO G
Citation: S. Cheradame et al., TUMORAL-REDUCED FOLATES AND CLINICAL RESISTANCE TO FLUOROURACIL-BASEDTREATMENT IN HEAD AND NECK-CANCER PATIENTS, Journal of clinical oncology, 15(7), 1997, pp. 2604-2610
CISPLATIN NEPHROTOXICITY - A MULTIVARIATE-ANALYSIS OF POTENTIAL PREDISPOSING FACTORS
Authors: LAGRANGE JL MEDECIN B ETIENNE MC PIVOT X CASSUTOVIGUIER E RENEE N THYSS A FERRERO JM OTTO J FRANCOIS E MILANO G
Citation: Jl. Lagrange et al., CISPLATIN NEPHROTOXICITY - A MULTIVARIATE-ANALYSIS OF POTENTIAL PREDISPOSING FACTORS, Pharmacotherapy, 17(6), 1997, pp. 1246-1253
DUAL MODULATION OF 5-FLUOROURACIL CYTOTOXICITY USING FOLINIC ACID WITH A DIHYDROPYRIMIDINE DEHYDROGENASE INHIBITOR
Authors: FISCHEL JL FORMENTO P ETIENNE MC SPECTOR T RENEE N MILANO G
Citation: Jl. Fischel et al., DUAL MODULATION OF 5-FLUOROURACIL CYTOTOXICITY USING FOLINIC ACID WITH A DIHYDROPYRIMIDINE DEHYDROGENASE INHIBITOR, Biochemical pharmacology, 53(11), 1997, pp. 1703-1709
LINK BETWEEN DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND LIVER
Authors: CHAZAL M ETIENNE MC RENEE N BOURGEON A RICHELME H MILANO G
Citation: M. Chazal et al., LINK BETWEEN DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND LIVER, Clinical cancer research, 2(3), 1996, pp. 507-510
SEVERE 5-FLUOROURACIL TOXICITY POSSIBLY SECONDARY TO DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY IN A BREAST-CANCER PATIENT WITH OSTEOGENESIS IMPERFECTA
Authors: BEUZEBOC P PIERGA JY LYONNET DS ETIENNE MC MILANO G POUILLART P
Citation: P. Beuzeboc et al., SEVERE 5-FLUOROURACIL TOXICITY POSSIBLY SECONDARY TO DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY IN A BREAST-CANCER PATIENT WITH OSTEOGENESIS IMPERFECTA, European journal of cancer, 32A(2), 1996, pp. 369-370
CRITICAL FACTORS FOR OPTIMIZING THE 5-FLUOROURACIL-FOLINIC ACID ASSOCIATION IN CANCER-CHEMOTHERAPY
Authors: ETIENNE MC GUILLOT T MILANO G
Citation: Mc. Etienne et al., CRITICAL FACTORS FOR OPTIMIZING THE 5-FLUOROURACIL-FOLINIC ACID ASSOCIATION IN CANCER-CHEMOTHERAPY, Annals of oncology, 7(3), 1996, pp. 283-289
LINK BETWEEN BASAL TUMORAL CONCENTRATIONS OF REDUCED FOLATES AND 5-FLUOROURACIL RESPONSIVENESS - CLINICAL-RESULTS
Authors: CHERADAME S ETIENNE MC SCHNEIDER M DEMARD F MILANO G
Citation: S. Cheradame et al., LINK BETWEEN BASAL TUMORAL CONCENTRATIONS OF REDUCED FOLATES AND 5-FLUOROURACIL RESPONSIVENESS - CLINICAL-RESULTS, Journal of clinical oncology, 14(5), 1996, pp. 2008-2008
DEVELOPMENT AND VALIDATION OF A CHIRAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY FOR ROGLETIMIDE AND ROGLETIMIDE-N-OXIDE ISOMERS IN PLASMA
Authors: ETIENNE MC OSTER W MILANO G
Citation: Mc. Etienne et al., DEVELOPMENT AND VALIDATION OF A CHIRAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY FOR ROGLETIMIDE AND ROGLETIMIDE-N-OXIDE ISOMERS IN PLASMA, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 343-348
IMPACT OF DIFFERENT FLUOROURACIL BIOCHEMICAL MODULATORS ON CELLULAR DIHYDROPYRIMIDINE DEHYDROGENASE
Authors: HAAZ MC FISCHEL JL FORMENTO P RENEE N ETIENNE MC MILANO G
Citation: Mc. Haaz et al., IMPACT OF DIFFERENT FLUOROURACIL BIOCHEMICAL MODULATORS ON CELLULAR DIHYDROPYRIMIDINE DEHYDROGENASE, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 52-58
INDIVIDUALIZING THERAPY WITH 5-FLUOROURACIL RELATED TO DIHYDROPYRIMIDINE DEHYDROGENASE - THEORY AND LIMITS
Authors: MILANO G ETIENNE MC
Citation: G. Milano et Mc. Etienne, INDIVIDUALIZING THERAPY WITH 5-FLUOROURACIL RELATED TO DIHYDROPYRIMIDINE DEHYDROGENASE - THEORY AND LIMITS, Therapeutic drug monitoring, 18(4), 1996, pp. 335-340
TUMORAL PLATINUM CONCENTRATIONS IN PATIENTS TREATED WITH REPEATED LOW-DOSE CISPLATIN AS A RADIOSENSITIZER
Authors: LAGRANGE JL BONDIAU PY TESSIER E CHAUVEL P RENEE N ETIENNE MC MILANO G
Citation: Jl. Lagrange et al., TUMORAL PLATINUM CONCENTRATIONS IN PATIENTS TREATED WITH REPEATED LOW-DOSE CISPLATIN AS A RADIOSENSITIZER, International journal of cancer, 68(4), 1996, pp. 452-456
AGE-RELATED DIFFERENCE IN TAMOXIFEN DISPOSITION
Authors: PEYRADE F FRENAY M ETIENNE MC RUCH F GUILLEMARE C FRANCOIS E NAMER M FERRERO JM MILANO G
Citation: F. Peyrade et al., AGE-RELATED DIFFERENCE IN TAMOXIFEN DISPOSITION, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 401-410
DIHYDROPYRIMIDINE DEHYDROGENASE - A TUMORAL TARGET FOR FLUOROURACIL MODULATION
Authors: FISCHEL JL ETIENNE MC SPECTOR T FORMENTO P RENEE N MILANO G
Citation: Jl. Fischel et al., DIHYDROPYRIMIDINE DEHYDROGENASE - A TUMORAL TARGET FOR FLUOROURACIL MODULATION, Clinical cancer research, 1(9), 1995, pp. 991-996
DIHYDROPYRIMIDINE DEHYDROGENASE AS A PIVOTAL TARGET FOR FU BIOMODULATION - ROLE OF 5-ETHYNYLURACIL
Authors: MILANO G FISCHELL J SPECTOR T ETIENNE MC FORMENTOL P
Citation: G. Milano et al., DIHYDROPYRIMIDINE DEHYDROGENASE AS A PIVOTAL TARGET FOR FU BIOMODULATION - ROLE OF 5-ETHYNYLURACIL, European journal of cancer, 31A, 1995, pp. 130-130
EARLY DETERMINATION OF CISPLATIN PLASMA-CONCENTRATION IS AN INDICATOROF RENAL DYSFUNCTION
Authors: PIVOT X MEDECIN B ETIENNE MC MILANO G BENSADOUN RJ TESSIER E LAGRANGE JL
Citation: X. Pivot et al., EARLY DETERMINATION OF CISPLATIN PLASMA-CONCENTRATION IS AN INDICATOROF RENAL DYSFUNCTION, European journal of cancer, 31A, 1995, pp. 953-953
Risultati: 1-25 | 26-50 | 51-51